F.D.A. Names and Shames Drug Makers to Encourage Generic Competition
Thursday, 17 May 2018
In its campaign to lower drug prices, the agency posted a list of brand-name manufacturers in an effort to force them to share drug samples with their generic rivals.
Credit: Wochit - Published
on May 17, 2018 < > Embed
Thursday, the Food and Drug Administration named drugmakers, including Celgene Corp., Johnson & Johnson, Gilead Sciences, and Novartis AG, as companies that are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop... ▶ FDA Names Drugmakers In Delaying Scandal 00:47
You Might Like
Recent related videos from verified sources
Can Generic Drugs Replace High Branded Drugs? 00:28
According to Business Insider, "High generic drug prices almost always stem from a lack of competition, but what drives this lack of competition can vary." That's why many companies are turning to..
Credit: Wochit - Published on December 21, 2018
U.S. Court Allows Generic Version Of Opioid Abuse Drug 00:39
According to Reuters, A U.S. appeals court on Tuesday allowed generic drug company Dr. Reddy’s Laboratories to sell a copycat version of the Indivior Plc opioid treatment Suboxone Film, sending..
Credit: Wochit Business - Published on November 20, 2018
Tweets about this
Other recent news in US